#India #AI Innovations #Ahmedabad #Veeda Lifesciences #Mango Sciences

Veeda Lifesciences Partners with Mango Sciences to Revolutionize Clinical Trials

In a significant move aimed at enhancing the efficiency of clinical trials, Veeda Lifesciences, a leading global Contract Research Organization (CRO), has announced its partnership with Mango Sciences, a Boston-based company specializing in artificial intelligence and data solutions for the healthcare sector. This partnership marks a pivotal step for Veeda as it aims to harness the power of AI to improve its clinical trial services across its expansive global network.

Investment in AI-Driven Solutions

Veeda’s investment in Mango Sciences represents a commitment to modernizing its operations through cutting-edge technology. By integrating Mango Sciences' Querent™ platform, driven by artificial intelligence, Veeda intends to streamline patient recruitment processes, making them more diverse and efficient while ensuring a globally representative selection of patients. Dr. Mahesh Bhalgat, the CEO of Veeda Clinical Research Limited, emphasized that this collaboration is set to transform the company into an AI-driven oncology drug development organization. This aligns with the increasing regulatory demand for diversity in clinical trials, ultimately benefiting pharmaceutical companies and patients alike.

Enhancing Operational Efficiency

The incorporation of Mango’s platform is expected to optimize several operational aspects of Veeda’s clinical trials. By automating patient identification processes and enhancing data management capabilities, the partnership aims to maintain higher quality standards while expanding its reach across Europe. Advanced data analytics will improve the matching of patients with suitable trials, refine study design, and enhance monitoring capabilities, which not only increases efficiency but also reduces overall trial costs and timelines.

Dr. Mohit Misra, the founder and CEO of Mango Sciences, highlighted that the integration of large language models (LLMs) and generative AI into the Querent™ platform will foster operational efficiency and improve real-world evidence outcomes, ensuring that the right drugs are matched with the right patients.

A Competitive Edge in Oncology Trials

Veeda Lifesciences has solidified its status as a technologically advanced CRO, making strategic investments that prioritize the adoption of AI. This partnership with Mango Sciences will provide Veeda with unique access to oncology cohorts in both India and Europe, as well as exclusive patient groups, reinforcing its competitive advantage in the CRO industry. The vision is clear: to support pharmaceutical and biopharmaceutical clients worldwide with enhanced services tailored to the evolving dynamics of drug development.

Commitment to Patient Representation

A core mission of both Veeda and Mango Sciences is to enhance patient representation in clinical trials. This partnership underscores the importance of diversity and inclusion, aiming to ensure that clinical research truly reflects the demographics of the patient population. By utilizing AI to not only speed up the trial process but also broaden its reach, both companies are committed to providing comprehensive healthcare solutions that address the needs of varied populations.

About Veeda Lifesciences

Veeda Lifesciences, including Veeda Clinical Research Limited, boasts a comprehensive service portfolio that supports various stages of drug development. They cater to small and medium-sized biotech and pharmaceutical companies, offering expertise from non-clinical and preclinical development to clinical pharmacology and diverse trial methodologies.

About Mango Sciences

Founded by seasoned professionals with extensive experience in healthcare, life sciences, and data analytics, Mango Sciences is dedicated to revolutionizing patient care through advanced data analysis and solutions. Their mission revolves around improving patient representation and access to comprehensive healthcare, making them an ideal partner for Veeda Lifesciences in this groundbreaking endeavor.

As Veeda Lifesciences moves forward with this transformative partnership, the potential to shape the future of clinical trials is immense, promising not just enhanced efficiencies but also a significant evolution in patient care and drug development practices.